Resources

Publish Date
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: U.S. Patent and Trademark Office
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on China and IP Theft
Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the American Music Fairness Act of 2025
Letters
C4IP Letter to USTR RE: US-EU Trade Agreement
Public Comments
C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025)
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Letters
C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing
Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025

Resources:

Resources:

C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence,

09/18/2025

Resources:

Resources:

C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions,

08/15/2025

Resources:

Resources:

Drug Competition Enhancement Act Infographic,

06/27/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act Infographic,

06/27/2025

Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Resources:

Resources:

Drug Competition Enhancement Act,

06/25/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act,

06/24/2025

Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025

Scroll to Top